ライブラリ登録: Guest
Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集
Critical Reviews™ in Eukaryotic Gene Expression
インパクトファクター: 1.841 5年インパクトファクター: 1.927 SJR: 0.649 SNIP: 0.516 CiteScore™: 1.96

ISSN 印刷: 1045-4403
ISSN オンライン: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukaryotGeneExpr.v13.i1.30
14 pages

The Cellular and Clinical Parameters of Anabolic Therapy for Osteoporosis

Clifford J. Rosen
Maine Medical Center Research Institute, USA

要約

A new era in the management of osteoporosis began with the recent approval of parathyroid hormone (PTH) for the treatment of postmenopausal osteoporosis. This peptide holds promise as the first in a series of anabolic growth factors that promote bone formation, enhance mineralization, and stimulate periosteal growth, yet exert relatively limited effects on bone resorption. Daily intermittent PTH treatment for postmenopausal women results in a dramatic increase in bone mineral density (BMD) (i.e., 10–15% improvement in spine BMD) and a significant decline (i.e., a risk reduction of nearly 2/3) in the occurrence of fragility fractures. The mechanism of PTH’s anabolic action on the skeleton is complex and involves multiple pathways linked to common signaling peptides that affect gene transcription in osteoblasts. One fascinating aspect of PTH, both at the clinical and molecular level, is the relationship between the frequency of PTH treatment and the bone response. Depending on the type of PTH exposure, there can be an anabolic or catabolic skeletal phenotype that can then be recapitulated by certain in vivo and in vitro model systems. Transcriptional events following ligand binding to the PTH/PTHrP1 receptor have been studied, with particular interest in target genes such as IGF-I that can regulate both bone formation and resorption. Novel in vivo strategies, including temporal and conditional mutagenesis, will almost certainly lead to newer therapeutic paradigms for the treatment of postmenopausal osteoporosis.


Articles with similar content:

Role of Bone Regeneration and Turnover Modulators in Control of Fracture
Critical Reviews™ in Eukaryotic Gene Expression, Vol.17, 2007, issue 3
Shimon Meretyk, Dina Lewinson, Michael Soudry, Nimrod Rozen, Tova Bick
Nmp4/CIZ Closes the Parathyroid Hormone Anabolic Window
Critical Reviews™ in Eukaryotic Gene Expression, Vol.22, 2012, issue 3
Fredrick M. Pavalko, Paul Childress, Joseph Bidwell, Yongzheng He, Feng-Chun Yang, Marta B. Alvarez, Mark Hood, Jr.,, Melissa A. Kacena
Mechanical Signaling for Bone Modeling and Remodeling
Critical Reviews™ in Eukaryotic Gene Expression, Vol.19, 2009, issue 4
Alexander G. Robling, Charles H. Turner
SLE-Associated Defects Promote Altered T Cell Function
Critical Reviews™ in Immunology, Vol.37, 2017, issue 1
Abel Suárez-Fueyo, Christian M. Hedrich, George C. Tsokos, Denis Comte, Jose C. Crispin
Mechanisms of Tumor Metastasis to Bone
Critical Reviews™ in Eukaryotic Gene Expression, Vol.10, 2000, issue 3&4
David Goltzman, Gurmit Singh, Shafaat Rabbani, Michael H. Weber, F. William Orr, Paul Kostenuik